Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Savant who wrote (1984)	8/11/2011 2:32:29 PM
From: donpat	Respond to of 12873

Re--That's quite an assumption-- Quite so! The DRACO drug is ONLY effective when the cell machinery is working to duplicate more virus - it needs that action to trigger a response: When viruses infect a cell, they take over its cellular machinery for their own purpose — that is, creating more copies of the virus. During this process, the viruses create long strings of double-stranded RNA (dsRNA), which is not found in human or other animal cells. ... Rider had the idea to combine a dsRNA-binding protein with another protein that induces cells to undergo apoptosis (programmed cell suicide) — launched, for example, when a cell determines it is en route to becoming cancerous. Therefore, when one end of the DRACO binds to dsRNA, it signals the other end of the DRACO to initiate cell suicide. http://medicalxpress.com/news/2011-08-drug-viral-infection.html When in hiding - the cell machinery is NOT turning out more virus, not creating dsRNA - thus the drug does NOT kill the virus. At least that is my take on what I read. How does one get at that hidden component? By enticing it out into the open for a Cide attack or make it decide to start making more virus for a DRACO attack! Must be a way!!!!